3-[3,4-Dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-4H-chromen-4-one(CAS: 116709-70-7)

This compound requires adherence to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substance identification. In terms of European regulations, it falls under REACH, which requires registration, evaluation, and authorization. For the United States, FDA and EPA regulations may apply for its use in pharmaceuticals or environmental releases, respectively. Specific handling and disposal procedures must comply with local and national laws.

There are several alternatives that can be used as starting materials or intermediates in the synthesis of similar compounds. Commonly, analogs such as 3,4-dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl derivatives or isomers of 3-[3,4-dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-4H-chromen-4-one can be utilized. Additionally, different reagents like acetylacetone or other chromone derivatives can serve as alternatives.

The market trend for this compound reflects increasing interest in chromones due to their potential in drug discovery and natural product chemistry. Research is focusing on understanding its biological activities, particularly in terms of antioxidant and anti-inflammatory properties. The compound is also being explored for pharmaceutical applications, which could drive its market growth.

Waste containing this compound should be collected in proper containers and stored in a secure, well-ventilated area. For disposal, professional waste treatment facilities should be used to ensure compliance with environmental regulations. Incineration may be a suitable method, but it must be conducted under controlled conditions to prevent the release of harmful byproducts. Always follow local and national waste disposal guidelines to ensure safety and environmental protection.